238 related articles for article (PubMed ID: 17157019)
21. Design, synthesis, and evaluation of novel aryl-tetrahydropyridine PPARalpha/gamma dual agonists.
Kim E; Park CS; Han T; Bae MH; Chong W; Lee CH; Shin YA; Ahn BN; Kim MK; Shin CY; Son MH; Kim JK; Moon HS; Shim HJ; Kim EJ; Kim SH; Lim JI; Lee CH
Bioorg Med Chem Lett; 2008 Sep; 18(18):4993-6. PubMed ID: 18771917
[TBL] [Abstract][Full Text] [Related]
22. Discovery of a novel series of peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes and dyslipidemia.
Liu K; Xu L; Berger JP; Macnaul KL; Zhou G; Doebber TW; Forrest MJ; Moller DE; Jones AB
J Med Chem; 2005 Apr; 48(7):2262-5. PubMed ID: 15801817
[TBL] [Abstract][Full Text] [Related]
23. Design and synthesis of substituted phenylpropanoic acid derivatives as human peroxisome proliferator-activated receptor alpha/delta dual agonists.
Kasuga J; Makishima M; Hashimoto Y; Miyachi H
Bioorg Med Chem Lett; 2006 Feb; 16(3):554-8. PubMed ID: 16275077
[TBL] [Abstract][Full Text] [Related]
24. Indanylacetic acid derivatives carrying 4-thiazolyl-phenoxy tail groups, a new class of potent PPAR alpha/gamma/delta pan agonists: synthesis, structure-activity relationship, and in vivo efficacy.
Rudolph J; Chen L; Majumdar D; Bullock WH; Burns M; Claus T; Dela Cruz FE; Daly M; Ehrgott FJ; Johnson JS; Livingston JN; Schoenleber RW; Shapiro J; Yang L; Tsutsumi M; Ma X
J Med Chem; 2007 Mar; 50(5):984-1000. PubMed ID: 17274610
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis, and evaluation of a novel series of alpha-substituted phenylpropanoic acid derivatives as human peroxisome proliferator-activated receptor (PPAR) alpha/delta dual agonists for the treatment of metabolic syndrome.
Kasuga J; Yamasaki D; Araya Y; Nakagawa A; Makishima M; Doi T; Hashimoto Y; Miyachi H
Bioorg Med Chem; 2006 Dec; 14(24):8405-14. PubMed ID: 16996742
[TBL] [Abstract][Full Text] [Related]
26. Design and biological evaluation of novel, balanced dual PPARalpha/gamma agonists.
Grether U; Bénardeau A; Benz J; Binggeli A; Blum D; Hilpert H; Kuhn B; Märki HP; Meyer M; Mohr P; Püntener K; Raab S; Ruf A; Schlatter D
ChemMedChem; 2009 Jun; 4(6):951-6. PubMed ID: 19326383
[TBL] [Abstract][Full Text] [Related]
27. Dual PPAR-alpha and -gamma activators derived from novel benzoxazinone containing thiazolidinediones having antidiabetic and hypolipidemic potential.
Madhavan GR; Chakrabarti R; Reddy KA; Rajesh BM; Balraju V; Rao PB; Rajagopalan R; Iqbal J
Bioorg Med Chem; 2006 Jan; 14(2):584-91. PubMed ID: 16198573
[TBL] [Abstract][Full Text] [Related]
28. Design and structural analysis of novel pharmacophores for potent and selective peroxisome proliferator-activated receptor gamma agonists.
Lin CH; Peng YH; Coumar MS; Chittimalla SK; Liao CC; Lyn PC; Huang CC; Lien TW; Lin WH; Hsu JT; Cheng JH; Chen X; Wu JS; Chao YS; Lee HJ; Juo CG; Wu SY; Hsieh HP
J Med Chem; 2009 Apr; 52(8):2618-22. PubMed ID: 19301897
[TBL] [Abstract][Full Text] [Related]
29. Design and synthesis of alpha-aryloxyphenylacetic acid derivatives: a novel class of PPARalpha/gamma dual agonists with potent antihyperglycemic and lipid modulating activity.
Shi GQ; Dropinski JF; McKeever BM; Xu S; Becker JW; Berger JP; MacNaul KL; Elbrecht A; Zhou G; Doebber TW; Wang P; Chao YS; Forrest M; Heck JV; Moller DE; Jones AB
J Med Chem; 2005 Jun; 48(13):4457-68. PubMed ID: 15974597
[TBL] [Abstract][Full Text] [Related]
30. Glucose transport-enhancing and hypoglycemic activity of 2-methyl-2-phenoxy-3-phenylpropanoic acids.
Sarges R; Hank RF; Blake JF; Bordner J; Bussolotti DL; Hargrove DM; Treadway JL; Gibbs EM
J Med Chem; 1996 Nov; 39(24):4783-803. PubMed ID: 8941393
[TBL] [Abstract][Full Text] [Related]
31. Structure-based design, synthesis, and nonalcoholic steatohepatitis (NASH)-preventive effect of phenylpropanoic acid peroxisome proliferator-activated receptor (PPAR) α-selective agonists.
Ban S; Kasuga J; Nakagome I; Nobusada H; Takayama F; Hirono S; Kawasaki H; Hashimoto Y; Miyachi H
Bioorg Med Chem; 2011 May; 19(10):3183-91. PubMed ID: 21530275
[TBL] [Abstract][Full Text] [Related]
32. Antidiabetic effect of a novel non-thiazolidinedione PPAR gamma/alpha agonist on ob/ob mice.
Hu X; Feng Y; Shen Y; Zhao XF; Yu JH; Yang YS; Leng Y
Acta Pharmacol Sin; 2006 Oct; 27(10):1346-52. PubMed ID: 17007742
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and evaluation of 2-alkoxydihydrocinnamates as PPAR agonists.
Lu Y; Guo Z; Guo Y; Feng J; Chu F
Bioorg Med Chem Lett; 2006 Feb; 16(4):915-9. PubMed ID: 16300944
[TBL] [Abstract][Full Text] [Related]
34. [Design, synthesis, and PPARalpha/gamma agonistic activity of novel tetrahydroisoquinoline derivatives].
Yu R; Zhou YL; Huan Y; Liu Q; Shen ZF; Liu ZZ
Yao Xue Xue Bao; 2011 Mar; 46(3):311-6. PubMed ID: 21626786
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and evaluation of carbazole derivatives as PPAR alpha/gamma dual agonists and antioxidants.
Kumar R; Ramachandran U; Srinivasan K; Ramarao P; Raichur S; Chakrabarti R
Bioorg Med Chem; 2005 Jul; 13(13):4279-90. PubMed ID: 15869880
[TBL] [Abstract][Full Text] [Related]
36. Peroxisome proliferator activated receptor alpha/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice.
Cha DR; Zhang X; Zhang Y; Wu J; Su D; Han JY; Fang X; Yu B; Breyer MD; Guan Y
Diabetes; 2007 Aug; 56(8):2036-45. PubMed ID: 17536062
[TBL] [Abstract][Full Text] [Related]
37. Ertiprotafib improves glycemic control and lowers lipids via multiple mechanisms.
Erbe DV; Wang S; Zhang YL; Harding K; Kung L; Tam M; Stolz L; Xing Y; Furey S; Qadri A; Klaman LD; Tobin JF
Mol Pharmacol; 2005 Jan; 67(1):69-77. PubMed ID: 15475571
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and evaluation of a series of benzopyran derivatives as PPAR alpha/gamma agonists.
Yu J; Tang L; Yang Y; Ji R
Eur J Med Chem; 2008 Nov; 43(11):2428-35. PubMed ID: 18329751
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, biological evaluation, and molecular modeling investigation of new chiral fibrates with PPARalpha and PPARgamma agonist activity.
Pinelli A; Godio C; Laghezza A; Mitro N; Fracchiolla G; Tortorella V; Lavecchia A; Novellino E; Fruchart JC; Staels B; Crestani M; Loiodice F
J Med Chem; 2005 Aug; 48(17):5509-19. PubMed ID: 16107150
[TBL] [Abstract][Full Text] [Related]
40. Modulation of PPAR subtype selectivity. Part 2: Transforming PPARα/γ dual agonist into α selective PPAR agonist through bioisosteric modification.
Zaware P; Shah SR; Pingali H; Makadia P; Thube B; Pola S; Patel D; Priyadarshini P; Suthar D; Shah M; Jamili J; Sairam KV; Giri S; Patel L; Patel H; Sudani H; Patel H; Jain M; Patel P; Bahekar R
Bioorg Med Chem Lett; 2011 Jan; 21(2):628-32. PubMed ID: 21195611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
